MedTrace Logo

Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)

NCT01526811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2021-11-02

No results posted yet for this study

Summary

The purpose of this study is to assess the benefits of endovascular repair with Endurant Stent Graft System by documenting overall mortality, complications, the rate of conversion to open surgical repair, and the development and rupture of the aneurysm on a long term, i.e. at 5 years, in a cohort of patients representative of the population treated under real-life conditions of use in France.

Conditions

Interventions

DEVICE

Endurant Stent graft

Endurant Stent graft implantation

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Jean-Pierre Becquemin, MD, PhD · Groupe Hospitalier Henri-Mondor, Créteil, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2018-12-21
Completion
2018-12-21

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01526811 on ClinicalTrials.gov